Probing the dynamics of doxorubicin-DNA intercalation during the initial activation of apoptosis by fluorescence lifetime imaging microscopy (FLIM).

Doxorubicin is a potent anthracycline antibiotic, commonly used to treat a wide range of cancers. Although postulated to intercalate between DNA bases, many of the details of doxorubicin's mechanism of action remain unclear. In this work, we demonstrate the ability of fluorescence lifetime imaging microscopy (FLIM) to dynamically monitor doxorubicin-DNA intercalation during the earliest stages of apoptosis. The fluorescence lifetime of doxorubicin in nuclei is found to decrease rapidly during the first 2 hours following drug administration, suggesting significant changes in the doxorubicin-DNA binding site's microenvironment upon apoptosis initiation. Decreases in doxorubicin fluorescence lifetimes were found to be concurrent with increases in phosphorylation of H2AX (an immediate signal of DNA double-strand breakage), but preceded activation of caspase-3 (a late signature of apoptosis) by more than 150 minutes. Time-dependent doxorubicin FLIM analyses of the effects of pretreating cells with either Cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl)-hydrazine (a histone acetyltransferase inhibitor) or Trichostatin A (a histone deacetylase inhibitor) revealed significant correlation of fluorescence lifetime with the stage of chromatin decondensation. Taken together, our findings suggest that monitoring the dynamics of doxorubicin fluorescence lifetimes can provide valuable information during the earliest phases of doxorubicin-induced apoptosis; and implicate that FLIM can serve as a sensitive, high-resolution tool for the elucidation of intercellular mechanisms and kinetics of anti-cancer drugs that bear fluorescent moieties.

Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.

Multidrug resistance (MDR) is the major clinical obstacle in the management of cancer by chemotherapy. Overexpression of ATP-dependent efflux transporter P-glycoprotein (PGP) is a key factor contributing to multidrug resistance of cancer cells. The purpose of the present study was to use the endosomal pH-sensitive MSN (mesoporous silica nanoparticles; MSN-Hydrazone-Dox) for controlled release of doxorubicin (Dox) in an attempt to overcome the PGP-mediated MDR. In vitro cell culture studies indicate that uptake of MSN-Hydrazone-Dox by the human uterine sarcoma MES-SA/Dox-resistant tumor (MES-SA/Dx-5) cell occurs through endocytosis, thus bypassing the efflux pump resistance. This improves the efficacy of the drug and leads to significant cytotoxicity and DNA fragmentation evidenced by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and DNA laddering assays. In vivo studies show that the intratumor injection of MSN-Hydrazone-Dox induces significant apoptosis of MES-SA/Dox-resistant cancer cells. This is validated by active caspase-3 immunohistochemical analysis. However, MSN-Hydrazone, without doxorubicin conjugation, cannot induce apoptosis in vitro and in vivo. In conclusion, both in vitro and in vivo studies show that MSN could serve as an efficient nanocarrier entering cell avidly via endocytosis, thus bypassing the PGP efflux pump to compromise the PGP-mediated MDR. MSN-Hydrazone-Dox could further respond to endosomal acidic pH to release doxorubicin in a sustained manner. Besides the cell study, this is the first report that successfully shows the therapeutic efficacy of using MSN against MDR cancer in vivo.

Probing the binding kinetics of proinflammatory cytokine-antibody interactions using dual color fluorescence cross correlation spectroscopy.

Dual color fluorescence cross correlation spectroscopy (FCCS) was used to investigate quantitatively the binding kinetics of tumor necrosis factor (TNFα) with TNFα antibody (anti-TNFα) following fluorescent labeling. Through the analysis of the auto correlation curves of fluorescence correlation spectroscopy (FCS), diffusion coefficients of 100.06 ± 4.9 µm(2) s(-1) and 48.96 ± 2.52 µm(2) s(-1) for Alexa488-TNFα and Atto647N-anti-TNFα were obtained. In addition, the calculated hydrodynamic diameters of the Alexa488-TNFα and Atto647N-anti-TNFα were approximately 4.89 ± 0.24 nm and 9.99 ± 0.52 nm, respectively, which agrees with the values of 5.20 ± 1.23 nm and 9.28 ± 0.86 nm for the native TNFα and the anti-TNFα as determined from dynamic light scattering measurements. For the binding kinetics, association (k(on)) and dissociation (k(off)) rate constants were (1.13 ± 0.08) × 10(4) M(-1) s(-1) and (1.53 ± 0.19) × 10(-3) s(-1) while the corresponding dissociation constant (K(d)) at 25 °C was (1.36 ± 0.10) × 10(-7) M. We believe this is the first report on the binding kinetics for TNFα-antibody recognition in the homogeneous phase. Using this technology, we have shown that controlled experiments can be performed to gain insight into molecular mechanisms involved in the immune response.

Photodissociation dynamics of fluorobenzene (C6H5F) at 157 and 193 nm: Branching ratios and distributions of kinetic energy.

Following photodissociation of fluorobenzene (C6H5F) at 193 and 157 nm, we detected the products with fragmentation-translational spectroscopy by utilizing a tunable vacuum ultraviolet beam from a synchrotron for ionization. Between two primary dissociation channels observed upon irradiation at 193 (157) nm, the HF-elimination channel C6H5F --> HF + C6H4 dominates, with a branching ratio of 0.94+/-0.02 (0.61+/-0.05) and an average release of kinetic energy of 103 (108) kJ mol(-1); the H-elimination channel C6H5F --> H + C6H4F has a branching ratio of 0.06+/-0.02 (0.39+/-0.05) and an average release of kinetic energy of 18.6 (26.8) kJ mol(-1). Photofragments H, HF, C6H4, and C6H4F produced via the one-photon process have nearly isotropic angular distributions. Both the HF-elimination and the H-elimination channels likely proceed via the ground-state electronic surface following internal conversion of C6H5F; these channels exhibit small fractions of kinetic energy release from the available energy, indicating that the molecular fragments are highly internally excited. We also determined the ionization energy of C6H4F to be 8.6+/-0.2 eV.

Photodissociation dynamics of formyl fluoride (HFCO) at 193 nm: branching ratios and distributions of kinetic energy.

Following photodissociation of formyl fluoride (HFCO) at 193 nm, we detected products with fragmentation translational spectroscopy utilizing a tunable vacuum ultraviolet beam from a synchrotron for ionization. Among three primary dissociation channels observed in this work, the F-elimination channel HFCO-->HCO+F dominates, with a branching ratio approximately 0.66 and an average release of kinetic energy approximately 55 kJ mol(-1); about 17% of HCO further decomposes to H+CO. The H-elimination channel HFCO-->FCO+H has a branching ratio approximately 0.28 and an average release of kinetic energy approximately 99 kJ mol(-1); about 21% of FCO further decomposes to F+CO. The F-elimination channel likely proceeds via the S1 surface whereas the H-elimination channel proceeds via the T1 surface; both channels exhibit moderate barriers for dissociation. The molecular HF-elimination channel HFCO-->HF+CO, correlating with the ground electronic surface, has a branching ratio of only approximately 0.06; the average translational release of 93 kJ mol(-1), approximately 15% of available energy, implies that the fragments are highly internally excited. Detailed mechanisms of photodissociation are discussed.

Molecular elimination in photolysis of fluorobenzene at 193 nm: internal energy of HF determined with time-resolved Fourier-transform spectroscopy.

Following photodissociation of fluorobenzene (C(6)H(5)F) at 193 nm, rotationally resolved emission spectra of HF(1

Photolysis of oxalyl chloride (ClCO)2 at 193 nm: emission of CO(v

Upon photolysis of oxalyl chloride at 193 nm, time-resolved and rotationally resolved emission of CO(v